Financial Disclosures

Celgene provides financial support to a range of organisations and initiatives that make a positive impact on our patients, our communities and our world, today and for years to come. We are committed to improving the lives of patients and focus our support in areas where we can make the greatest impact.

Payments to Patient Groups

In 2018, Celgene provided payments to, or on behalf of, the following patient groups in the UK:

ACLT – AFRICAN CARIBBEAN LEUKAEMIA TRUST

  • 2017 Grant towards local donor drives to recruit BME (Black Minority Ethnic) individuals to blood, bone marrow and/or organ donor registers – £15,000.
  • 2018 Grant towards local donor drives to recruit BME (Black Minority Ethnic) individuals to blood, bone marrow and/or organ donor registers – £15,000.

BLOODWISE

  • 2018 Grant to support the development of a portfolio materials about CAR T through the Bloodwise website – £10,000.
  • Consultancy fee for attendance at CAR T patient group advisory board – £800.
  • 2017 Grant towards Blood Cancer Connect: the online resource for blood cancer patients – £15,000.

CANCER 52

  • 2018 Grant towards the production of a charter for rare and less common cancers – £7,500.
  • 2017 Grant towards membership workstream including: information updates, quarterly all member meetings, workshops, ongoing communication through social media and annual all stakeholder briefing – £15,000.

EUROPACOLON UK

  • 2018 Grant to support Masterclass and World Pancreatic Cancer day activities, patient support project and carers project €12,500.

GWENT DERMATOLOGY PATIENT PANEL

  • Grant to support ongoing work of Gwent Dermatology Patient Panel – £3,870.

LEUKAEMIA CARE SOCIETY

  • Sponsorship of Leukaemia Care Acute Leukaemia Nurse Education Day – 9th November 2018 – £750.
  • Consultancy fee for attendance at CAR T patient group advisory board – £400.
  • 2018 Grant towards the development of patient information and patient videos – £20,000.
  • 2017 Grant towards core patient support services including: patient education and information, 24 hour care line and nurse advisor – £15,000.
  • Sponsorship of 2017 Leukaemia Care Nurse Study Day – 17 November 2017 – £750.

LYMPHOMA ACTION

  • Consultancy fee for input into Celgene CAR T clinical trial programme – £570.
  • Consultancy fee for attendance at CAR T patient group advisory board – £800.
  • 2018 Grant to support core information and support services for people who are affected with Lymphatic cancer including: publications, the Haemato-Oncology diagnostics course, regional ‘Focus on Lymphoma’ study days, the patient conference on 12th May and Know your Lymphoma-subtype specific webinars – £15,000.
  • Travel expenses for attendance at Celgene Changemakers Patient Group Summit – £169.55.

MULTIPLE SCLEROSIS INTERNATIONAL FEDERATION (MSIF)

  • Grant to support World MS Day 2017 – $15,000.
  • Grant to support World MS Day 2018 – $10,000.
  • Grant to support Access to Effective Treatment project – $15,000.
  • Grant to support Atlas of MS project – $7,500.
  • Grant to support informed decision making project – $7,500.
  • Grant to support informed decision making project – $7,500.
  • Grant to support Capacity building project – $15,000.

MULTIPLE SCLEROSIS TRUST

  • 2018 Medical Information stand at MS Trust annual conference 4-6th November – £2,000.

MYELOMA UK

  • Consultancy fee for presentation and attendance at Myeloma Journalist Education Event – £480.
  • Consultancy fee and expenses for presentation and attendance at National Haematology Nurse meeting – £1089.69.
  • Sponsorship towards Myeloma UK London to Paris Bike Ride 2018 – £10,000.
  • 2018 Grant towards Myeloma UK’s support to patients and families living with Multiple Myeloma including: Patient Information and Support, Educational Resources for Healthcare Professionals, Patient Advocacy, Health Services Research – £110,000.
  • Consultancy fee for attendance at CAR T patient group advisory board – £800.
  • Consultancy fee and travel expenses for presentation and attendance at West Midlands Myeloma CNS/Pharmacy study day – £854.05
  • 2017 Grant towards Myeloma UK’s support to patients and families living with Multiple Myeloma including: Patient Information and Support, Educational Resources for Healthcare Professionals, Patient Advocacy, Health Services Research – £110,000.

PANCREATIC CANCER ACTION

  • 2017 Winner of ImpactPanc award program for raising awareness of pancreatic cancer – £20,000.

PANCREATIC CANCER UK

  • Sponsorship towards the launch of the Less Survivable Cancers Taskforce on 19th July 2017 – £5,000.
  • 2017 Grant towards Pancreatic Cancer UK National Study Day on 9th October 2017and Annual Summit on 1st March 2018 – £30,000.

PSORIASIS ASSOCIATION

  • Corporate sponsorship 2017 – £1,500.
  • Corporate sponsorship 2018 – £1,500.
  • Consultancy fee for moderate patient research – £5,000.
  • Consultancy fee for Life’s An Itch campaign – £5,000.

UK MDS PATIENT SUPPORT GROUP

  • Consultancy fee for participation at MDS Awareness Day Radio Day – October 2018 – £560.
  • 2017 Grant to support information and support for MDS patients and their families – £34,000.

VERSUS ARTHRITIS Formally known as ARTHRITIS RESEARCH UK

  • Sponsorship of Versus Arthritis launch event – £5,000.
  • Grant to support the ongoing work on Arthritis Research UK – £22,000.

WORLD CHILD CANCER

  • 2017 Donation to World Child Cancer – $50,000.
  • 2018 Donation to World Child Cancer – $100,000.

 

Financial disclosures for 2017
Financial disclosures for 2016
Financial disclosures for 2015
Financial disclosures for 2014
Financial disclosures for 2013
Financial disclosures for 2012


NP-UK-NA-0101 Date of preparation: April 2019